with an area under curve of 0.2393 indicating that for every meter increase in 6-min walk test, it is 1.38% less likely to have complications with an odds ratio of 0.986 (95% C.I. 0.978 to 0.995; P = 0.002).
the kinetics of VO2 during SBT and its prognostic significance in tracheostomized patients with prolonged mechanical ventilation (PMV).
Methods:
We used an open circuit method to continuously measure the breath-by-breath VO2 (by CARESCAPE Monitor B650, GE Healthcare, US) during SBT for PMV patients with tracheostomy at a weaning unit. The kinetics of VO2 during SBT were analyzed and compared between patients grouped by the result of SBT Results: Between January and June 2018, 24 patients completed the study, aged 68.7 AE 13.6 years and had 43.9 AE 26.1 days of MV before inclusion. The most common reasons for initiating MV were pneumonia (54%) and heart failure (21%). The VO2 data were collected with a duration of 781 AE 393 min , and 20 patients successfully passed the SBT. The overall mean VO2 level was 237.1 AE 44.3 ml/min. The SBT success cases had a significantly lower level of mean VO2 than the failure cases (224.4 AE 32.6 vs 297.4 AE 23.4 ml/min; P < 0.001). The time proportion of VO2 >250 ml/min was 28 AE 28% in the success cases, in contrast to 91 AE 12% who failed; the time proportion was highly correlated to SBT results, with an AUC of ROC curve of 0.98 (Youden index 0.90). Using the time proportion of 64.6% as a cutoff for predicting SBT failure, the sensitivity and specificity was 90% and 100%, respectively. Results: Analysis of supernatant of bronchial aspiration from ARDS patients (n = 20) showed elevated NETs and Caspase-1 were significantly correlated with the degree of ARDS and were higher in nonsurvivors (1865 AE 191.6, 35 .7 AE 3.097, n = 7) than in survivors (1300 AE 119.7, 26.94 AE 1.659, n = 13). DNase and PAD4 inhibitor markedly attenuated the pyroptosis ratio of alveolar macrophages and the intensity of ARDS. 
Conclusion

